The authors for [1] would like to make the following clarification:
The genetic analyses in Case 1 identified two copies of the SMN1 gene and one copy of the SMN2 gene. These results indicated that this patient was unlikely to be affected with, or predisposed to developing, the clinical symptoms associated with Spinal Muscular Atrophy (SMA).
The authors would like to apologize for the error and regret any confusion or inconvenience caused.
REFERENCE
- 1. Huang Eric J., Zhang Jiasheng, Geser Felix, Trojanowski John Q., Strober Jonathan B., Dickson Dennis W., Robert H. Brown, Jr , Shapiro Barbara E., Lomen‐Hoerth Catherine (2010) Extensive FUS‐Immunoreactive Pathology in Juvenile Amyotrophic Lateral Sclerosis with Basophilic Inclusions. Brain Pathol 20:1069–1076. [DOI] [PMC free article] [PubMed] [Google Scholar]